23andMe Faces Legal and Financial Turmoil Amid Auction Battles
TL;DR Summary
Twenty-seven states and D.C. sued to block 23andMe from selling personal genetic data without customer consent amid its bankruptcy and a proposed sale to Regeneron, citing privacy concerns and the need for informed consent for sensitive health information.
- Dozens of states sue to block the sale of 23andMe personal genetic data NPR
- 23andMe’s Former CEO Pushes Purchase Price Nearly $50 Million Higher WSJ
- 23andMe Sets New Auction With $305 Million New Bid From Ex-CEO Bloomberg
- 23andMe back on the auction block after former CEO makes 11th-hour bid The Guardian
- I worked at 23andMe during its collapse. Here’s what the next consumer-genomics giant needs to understand statnews.com
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
1 min
vs 2 min read
Condensed
87%
287 → 38 words
Want the full story? Read the original article
Read on NPR